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Selenium is a vital micronutrient in many organisms. While traces are required for survival, 
excess amounts are toxic; thus, selenium can be regarded as a biological “double-edged sword”. 
Selenium is chemically similar to the essential element sulfur, but curiously, evolution has selected 
the former over the latter for a subset of oxidoreductases. Enzymes involved in sulfur metabolism 
are less discriminate in terms of preventing selenium incorporation; however, its specific 
incorporation into selenoproteins reveals a highly discriminate process that is not completely 
understood. In this work, we add knowledge to the mechanism for selenium-over-sulfur specificity 
in hopes of further understanding the controlled regulation of selenium trafficking and the 
prevention of its toxicity. We have identified SclA, a selenocysteine lyase in the nosocomial 
pathogen, Enterococcus faecalis, and characterized its enzymatic activity and specificity for L-
selenocysteine over L-cysteine. Human selenocysteine lyase contains a residue, D146, which plays 
a significant role in determining its specificity. A D146K mutation eliminated this trait, allowing 
non-specific L-cysteine degradation. Using computational biology, we identified an orthologous 
residue in SclA, H100, and generated mutant enzymes with site-directed mutagenesis. The proteins 
were overexpressed, purified, and characterized for their biochemical properties. All mutants 
exhibited varying levels of activity towards L-selenocysteine, hinting at a catalytic role for H100. 
Additionally, L-cysteine acted as a competitive inhibitor towards all enzymes with higher affinity 
than L-selenocysteine. Finally, our experiments revealed that SclA possessed extremely poor 
cysteine desulfurase activity with each mutation exhibiting subtle changes in turnover. Our 
findings offer key insight into the molecular mechanisms behind selenium-over-sulfur specificity 
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CHAPTER 1: INTRODUCTION 
Selenium and its Role in Biology 
Selenium is an important trace element found in all known domains of life. In many 
organisms, selenium functions as an essential micronutrient when present in small amounts, but in 
excess, the reactive nonmetal becomes highly toxic and therefore must be kept under tight 
regulation—this phenomenon is why selenium is often regarded as a “double-edged sword” in 
biology. Selenium shares many properties with the nonmetal, sulfur, as both elements are part of 
the chalcogens group on the periodic table. While both elements are similar in terms of atomic 
character and involvement in redox reactions, sulfur is much more abundant in nature as a 
macronutrient compared to the uncommon selenium.  
The most well-characterized biological form of selenium is selenocysteine, the 21st amino 
acid [1, 2]. Unlike the standard twenty proteinogenic amino acids, selenocysteine is genetically 
encoded by the UGA stop codon; specifically, a stem loop structure termed the SECIS element 
(selenocysteine insertion sequence) and tRNASec reprogram the codon for selenocysteine insertion 
into the nascent polypeptide rather than premature termination of translation [3, 4]. In bacteria, 
this process is mediated by the following gene products: SelA, SelB, selC, and SelD [2, 5, 6]. 
Interestingly, selenocysteine possesses chemical attributes that are not present in its sulfur analog, 
cysteine. First, the selenol group of selenocysteine has a pKa of ~5.2 while the thiol group of 
cysteine has a pKa of ~8.5; because of this, at physiological pH, free selenocysteine is extremely 
reactive as a result of its deprotonated side chain while cysteine’s protonated side chain renders it 
less reactive in comparison [7]. Second, selenocysteine can resist over-oxidation in some redox-
dependent enzymes such as thioredoxin reductase while cysteine usually cannot recover from such 
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a destructive event [8]. Lastly, the presence of a selenocysteine residue in the active sites of redox-
active enzymes generally confers a catalytic advantage compared to their cysteine-containing 
homologs and mutants [9-11]. These subtle properties regarding selenium can be seen as 
evolutionary favorable in the context of some biological systems. 
Biological Incorporation of Selenium 
While the aforementioned redox advantages of selenium imply a vast difference between 
it and sulfur, biology often has a difficult time distinguishing between the two atoms. In most cases 
when cells contain a high selenium-to-sulfur ratio, selenium is misincorporated into biomolecules 
in place of sulfur based on the lack of specificity of key sulfur metabolic enzymes which are non-
discriminate and fail to prevent the insertion of selenium into these molecules—this mechanism is 
still not completely understood [12]. In bacteria, these key enzymes are O-acetylserine 
sulfhydrylase (CysK) and cysteinyl-tRNA synthetase (CysRS); CysK respectively generates 
cysteine and selenocysteine using sulfide (HS-) and selenide (HSe-), while CysRS can mischarge 
tRNACys with selenocysteine instead of cysteine [12, 13]. Therefore, via the non-specific 
incorporation pathway, the cysteines and methionines of proteins are inadvertently replaced by 
selenocysteines and selenomethionines, respectively [12, 14-18]. It is important to note that the 
misincorporation of sulfur in place of selenium has not been observed in vivo, heavily implying 
that the enzymes involved in selenium metabolism are much stricter than their sulfur metabolic 
counterparts in the discrimination of the two chalcogens. In an environment where cells contain a 
high sulfur-to-selenium ratio, a specific incorporation pathway dominates where selenium is 
purposefully inserted into biomolecules in three different ways. First, as previously stated, 
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selenium can be specifically incorporated as selenocysteine into proteins (called selenoproteins) 
through a recoded stop codon; as mentioned earlier, the reactivity of selenocysteine greatly 
influences the catalytic properties of selenoproteins. Second, selenium can also be incorporated 
into the wobble position of some tRNAs as 2-selenouridine, but the role of this modification is 
poorly understood [19-21]. Finally, selenium can be incorporated as a labile cofactor into the active 
sites of certain molybdenum hydroxylases, often playing a role in enzyme catalysis [22-25]. Since 
many organisms require selenium for life, it seems logical that the specific incorporation pathway 
functions to provide the trace element to fill that critical need in the presence of immense amounts 
of sulfur. 
The specific incorporation of selenium requires the presence of an enzyme called 
selenophosphate synthetase (SPS); in bacteria, SPS is the gene product of selD [26]. The product 
of SPS is selenophosphate (SePO3), a molecule with high group transfer potential which functions 
as a biochemical currency similar to adenosine triphosphate (ATP) by donating selenium to the 
specific incorporation pathways [27]. Because SePO3 is rarely present in the cytoplasm, SPS must 
generate it via an ATP-dependent process using its preferred substrate: HSe- [26]. Although a 
precursor to SePO3, HSe
- is highly reactive and likely very toxic to the cell, often redox cycling 
with intracellular thiols and rapidly generating reactive oxygen species such as superoxide [28, 
29]. Nevertheless, if HSe- is required for the production of SePO3 and ultimately the biosynthesis 
of selenium-containing biomolecules, then it must be generated in a controlled manner. One way 
this occurs is through the biochemical discrimination of selenium and sulfur. For example, in 
Escherichia coli, SPS exhibits a type of substrate specificity where it only recognizes HSe- and 
produces SePO3; the enzyme does not generate thiophosphate (SPO3) from HS
- [30]. This concept 
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in selenium biochemistry is poorly understood especially considering how the cellular 
concentration of HSe- pales in comparison to the substantial amount of HS- in the cytosol—the 
ability for an enzyme to recognize a selenium atom amongst an enormous pool of sulfur would 
most likely require a sophisticated mechanism. Coincidentally, the best candidates to study this 
mechanism are enzymes from the NifS-like protein family for which a small subset is involved in 
selenium-over-sulfur discrimination. 
The NifS-like Protein Family 
 NifS-like proteins are pyridoxal 5’-phosphate (PLP)-dependent aminotransferases, 
homologous to the nifS (nitrogen fixation) gene product in Azotobacter vinelandii: NifS [31]. This 
enzyme functions as a cysteine desulfurase (CDS) where it degrades L-cysteine into L-alanine and 
HS- [31, 32]. After L-cysteine degradation, the sulfur atom is covalently bound to the catalytic 
thiolate of the CDS through a persulfide intermediate; with the help of an array of scaffolding 
proteins, the inorganic sulfur is subsequently mobilized to important biomolecules such as iron-
sulfur (Fe-S) cluster-containing proteins, thiamine, and molybdenum cofactor, demonstrating a 
clear role for CDSs in vivo [32]. The majority of knowledge stems from analyses on the known 
CDSs in E. coli: IscS, CSD (CsdA), and SufS (CsdB). While the three enzymes recognize L-
cysteine as their primary substrate, they also nonspecifically act on L-selenocysteine with varying 
degrees of activity [32-36]. On the other hand, a subset of NifS-like enzymes acts specifically on 
L-selenocysteine with no regard to the L-cysteine pool within the cell, thus exhibiting 
selenocysteine lyase (SCL) activity and therefore degrading L-selenocysteine into L-alanine and 
HSe- [37, 38]. Moreover, SCLs are curiously inhibited by L-cysteine in either a competitive or 
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non-competitive manner, depending on the enzyme [37-39]. Because SCLs generate HSe-, it is 
possible that they may be involved in channeling selenium into the specific incorporation pathway, 
analogous to how CDSs mobilize sulfur to certain biomolecules—this may be primarily mediated 
by its selenium-over-sulfur discriminatory ability. Unfortunately, this is speculative without clear 
evidence of the exact mechanism by which this occurs, and because the knowledge on SCLs is so 
scarce, their role in vivo has not yet been identified. The lack of information rises from the fact 
that most of the SCLs that have been biochemically characterized are from mammals where 
selenium metabolism is not as understood as it is in prokaryotes [37, 39, 40]. In bacteria, several 
SCLs were reported to have been found, but only one of them was purified and characterized from 
the crude lysate of Citrobacter freundii [38, 41]. Indeed, characterizing putative SCLs that are 
already identified in selenium-utilizing organisms would help us gain more knowledge on their 
biological function. 
A Selenocysteine Lyase in Enterococcus faecalis 
While studying the selenium metabolism of several pathogens, our lab identified a NifS-
like protein in Enterococcus faecalis [42]. E. faecalis is a multidrug-resistant pathogen and a 
prominent nosocomial responsible for endocarditis, bacteremia, and urinary tract infections [43]. 
Aside from these diseases, its alarming ability to effortlessly form biofilms on the surfaces of 
medical devices such as catheters and pacemakers makes it an ongoing healthcare issue [44]. 
Curiously, E. faecalis has been identified as an organism that harbors an “orphan selD” in the sense 
that it does not contain the genes necessary to synthesize selenoproteins or selenium-containing 
tRNAs but instead may utilize SePO3 for some other unknown trait [42, 45]. Additionally, genes 
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that are putatively involved with the biosynthesis of a selenium-dependent molybdenum 
hydroxylase (SDMH) were identified in the same genetic locus as selD [42, 46].  
We have previously demonstrated that the SDMH in question is a xanthine dehydrogenase 
(XDH) that has been shown to significantly increase biofilm formation in the presence of uric acid, 
molybdate, and selenite [47]. In the same genetic locus, many uncharacterized genes were 
annotated to be hypothetically involved in selenium metabolism—one of which is EF2568, whose 
gene product encodes a putative NifS-like protein [42]. We have previously shown through cloning 
and biochemical characterization that the gene product of EF2568 is an SCL due to its specificity 
for L-selenocysteine over L-cysteine [48]. Based on our initial characterization of the protein and 
the fact that it may be involved in selenium trafficking according to the gene’s location amongst 
other selenium-related genes, we hereby propose a renaming of the open reading frame to sclA 
(selenocysteine lyase). Its true role in vivo, however, is still unclear, and the mechanism by which 
it specifically recognizes selenium is unknown. 
The Mechanism for Selenium-over-Sulfur Specificity 
In NifS-like enzymes, the catalytic mechanism for cysteine degradation follows a general 
two-step procedure. First, the substrate (L-cysteine) binds to PLP in the active site, forming an 
external aldimine linkage; afterwards, the thiolate ion of the core catalytic cysteine residue 
nucleophilically attacks the chalcogen atom of the substrate-PLP complex, yielding a sulfur atom 
bound to the cysteine residue via a persulfide linkage and producing free L-alanine [49]. The 
ionization state of the cysteine residue’s side chain is key to the catalysis, but it may also play a 
role in discriminating between sulfur and selenium. In CDSs, the deprotonated thiolate anion is 
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dominant, acting as a nucleophile to non-specifically attack the sulfur of L-cysteine or the selenium 
of L-selenocysteine. In SCLs, however, it is believed that the protonated thiol group is preferred 
in order to offer specificity towards L-selenocysteine. Because the protonated thiol is mostly 
unreactive and does not act as a potent nucleophile compared to the thiolate, it is unclear how the 
reaction would proceed in general. 
A recent investigation into the selenium-over-sulfur specificity mechanism of human SCL 
(hSCL) has shed some light on this topic. By using a site-directed mutagenesis approach on hSCL, 
the authors found that mutation of the aspartic acid at amino acid position 146 (D146) to a lysine 
(D146K) resulted in novel activity towards L-cysteine that had been previously absent [50, 51]. In 
other words, the enzyme became non-discriminate and effectively switched from an SCL to a CDS 
with a single point mutation. This seems to imply that D146 is either the sole determinant of 
selenium specificity or at least plays a significant role in the mechanism. Specifically, the authors 
proposed that, while a protonated thiol could not react with the thiol of L-cysteine, the nucleophilic 
selenolate anion of L-selenocysteine may deprotonate the cysteine residue’s thiol which could then 
attack the electrophilic selenol group, causing the reaction to proceed with high specificity for 
selenium [51]. In this case, it is believed that the nearby carboxylate anion of D146 serves to 
increase the pKa of C388 (the catalytic cysteine) through a like-charge destabilization of its thiolate 
anion; thus, the protonated thiol form would dominate, allowing only reaction with L-
selenocysteine. When D146 was mutated to a lysine, the charge was inverted and may have 
reduced the pKa of C388. It is possible that the lysyl side chain’s amino cation stabilized the 
deprotonated thiolate species, allowing C388 to react with both substrates. Overall, this implies 
that the presence of D146 heavily influences the pKa of C388 and may prevent the residue from 
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achieving the thiolate form present in other NifS-like enzymes. It should be noted, however, that 
the pKa of the active site cysteine was not determined in this study. 
Because D146K of hSCL was reported to eliminate L-selenocysteine specificity, we 
wondered if an orthologous residue in SclA shared a similar role in influencing the pKa of its 
catalytic cysteine. Aligning the primary sequence of hSCL to SclA revealed a histidine at amino 
acid position 100 (H100) in SclA that directly aligns to D146, implying that the former may also 
function as a determinant of selenium-over-sulfur specificity [48]. In this work, we set out to 
determine the function of H100 through a site-directed mutagenesis approach based on the 
previous work on hSCL. We hope that the results of this work further add knowledge to the 
mechanism of selenium-over-sulfur discrimination and give insight as to how SCLs play a role in 





CHAPTER 2: MATERIALS AND METHODS 
Materials 
Oligonucleotides were purchased from Integrated DNA Technologies. T4 DNA ligase, T4 
DNA ligase reaction buffer, T4 Polynucleotide Kinase (PNK), Q5 High-Fidelity DNA Polymerase 
(Q5), Q5 reaction buffer, Q5 High GC Enhancer, Deoxynucleotide (dNTP) Solution Mix, and 
DpnI were all purchased from New England Biolabs. E. coli strains NEB 5-α and Lemo21(DE3) 
were purchased from New England Biolabs. Gel Loading Dye Blue (6×) and TriDye 1 kb DNA 
Ladder were purchased from New England Biolabs. Pierce Universal Nuclease for Cell Lysis and 
HisPur Cobalt Resin were purchased from Thermo Fisher Scientific. Spectra Multicolor Broad 
Range Protein Ladder was purchased from Thermo Fisher Scientific. The French Press and the 
Manual-Fill 40K Cell (FA-032) were purchased from Glen-Mills. Bio-Rad Protein Assay Dye 
Reagent Concentrate (Bradford reagent) was purchased from Bio-Rad. Q Sepharose Fast Flow was 
purchased from GE Healthcare. L-Selenocystine was purchased from Acros Organics. L-Cysteine 
hydrochloride monohydrate was purchased from Alfa Aesar. 
Growth Media and Bacterial Maintenance 
All E. coli strains were maintained with lysogeny broth (LB) as per the Lennox formulation 
(1.0% tryptone, 0.5% yeast extract, 0.5% NaCl) [52-54]. For solid media, LB was supplemented 
with 1.5% agar. Unless stated otherwise, E. coli strains used specifically for protein expression 
were maintained using LB supplemented with 2 KOH pellets per liter, 0.2% glucose, 0.2% 
glycerol, and 200 μg/mL ampicillin—this medium is referred to as “modified LB” in this work. 
Modified LB supplemented with 1.5% agar was used to maintain these strains on solid media. For 
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overnight starter cultures, modified LB was supplemented with 1 mM MgSO4. For overexpression 
cultures, modified LB was supplemented with 1 mM MgSO4 and 0.1 mM pyridoxine, but glucose 
was omitted entirely. For starter cultures and smaller volumes, the Barnstead MaxQ 4000 orbital 
shaker was used. For overexpression cultures and larger volumes, the New Brunswick Innova 4230 
shaker was used. All agitation steps were carried out at 240 rpm. 
Sequence Alignments and Homology Modeling 
FASTA sequences of various characterized NifS-like enzymes were selected and aligned 
using Clustal Omega [55]. These sequences were obtained from the following UniProt IDs: 
Q96I15 (hSCL), Q831E3 (E. faecalis SclA), O32164 (Bacillus subtilis SufS), P77444 (E. coli 
SufS/CsdB), Q46925 (E. coli CSD/CsdA), P0A6B7 (E. coli IscS), and P05341 (A. vinelandii 
NifS). The sequences were ordered by input as shown in Figure 1. 
To create 3-D structures of hSCL and SclA for active site analysis, the following methods 
were used. The Protein Data Bank (PDB) ID of hSCL, 3GZC, was used to generate a 3-D structure 
using PyMOL [56]. Because no crystal structure of SclA existed at the time of this writing, it had 
to be modeled in a different manner. The aforementioned FASTA sequence of SclA was used to 
find templates of closest putative structural homology using ExPASy’s SWISS-MODEL [57]. The 
SclA sequence was then threaded through the top result, B. subtilis SufS (PDB ID: 5J8Q), to 
generate a hypothetical structural model. The data for this homology model were converted to a 
PDB format and then used to generate a 3-D structure using PyMOL. D146K and H100 mutants 




The pET100 vector designated as pRT1 containing sclA (EF2568) cloned from E. faecalis 
V583 was subjected to ‘Round-the-horn site-directed mutagenesis [58, 59]. Briefly, primers were 
designed with the intent to mutate the histidine at amino acid position 100 to the following 
residues: lysine (H100K), aspartate (H100D), alanine (H100A), and asparagine (H100N). Forward 
primers contained the mutated codons on the 5’ ends while the reverse primer was designed to 
bind directly next to the site of mutation. All primers were designed to have a melting temperature 
of ~60 °C and are referenced in Table 1. Primers were phosphorylated by incubating a 50 μL 
mixture containing 1× T4 DNA ligase reaction buffer, 10 μM primers, and 1 μL of PNK (10,000 
U/mL) at 37 °C for 1 hour; afterwards, the PNK was inactivated with a final 5-minute incubation 
at 95 °C. For each point mutant, several 50 μL master mixes of the following reagents were 
prepared on ice: 1× Q5 reaction buffer, 1× Q5 High GC Enhancer, 300 nM forward and reverse 
primers, 0.2 mM dNTPs, 0.5 ng of pRT1, and 0.5 μL of Q5 (2,000 U/mL). To perform the 
polymerase chain reaction (PCR), the master mixes were placed in a Techne TC-312 thermal 
cycler with a pre-heated lid and were initially denatured at 98 °C for 1 minute. Afterwards, the 
following program was cycled through 27 times: denaturation at 96 °C for 30 seconds, annealing 
at 64 °C for 30 seconds, and extension at 72 °C for 14 minutes. Finally, samples were cooled at 18 
°C for 1 minute. To check for PCR products, 5 μL samples were mixed with 2 μL of Gel Loading 
Dye Blue (6×). From these samples, 5 μL along with 5 μL of TriDye 1 kb DNA Ladder were 
loaded on a 1% agarose gel prepared with 1× Tris-acetate-EDTA (TAE, 40 mM 
tris(hydroxymethyl)aminomethane [Tris], 20 mM acetate, 10 mM ethylenediaminetetraacetate 
[EDTA]) and 0.5 μg/mL ethidium bromide and were electrophoresed at 100 V for 30 minutes. 
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Gel Extraction and Ligation 
After mutagenesis, samples were treated with 1 μL of DpnI (20,000 U/mL) and incubated 
at 37 °C for 1 hour to digest the template plasmid. Digested samples were electrophoresed on a 
1% agarose gel prepared with 1× TAE and 0.005% crystal violet at 100 V for 30 minutes. The 
target bands were excised with a sterile razor blade, transferred to 1.7 mL microcentrifuge tubes 
containing 500 μL of gel melting buffer (5.5 M guanidinium thiocyanate, 0.1 M sodium acetate, 
[pH 5.0]), and melted in a Fisher Isotemp 210 water bath at 50 °C for 10 minutes. After samples 
were fully dissolved and denatured, 150 μL of 100% isopropanol were added to each tube and 
vortexed thoroughly. Unless otherwise stated, all centrifugation steps regarding spin columns for 
the rest of this work were carried out using an Eppendorf 5418 centrifuge. Denatured samples were 
bound to DNA Mini-Spin Columns (Enzymax LLC) and centrifuged twice at 2,000 × g for 1 
minute to discard the non-bound flow-through. An additional 300 μL of gel melting buffer were 
added to each sample, and each tube was centrifuged at 2,000 × g for 1 minute. Samples were 
washed with a column wash buffer (5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonate-KOH 
[HEPES-KOH], 20 mM NaCl, 0.02 mM EDTA, 80% ethanol, [pH 8.3]) three times at decreasing 
volumes per wash: 400 μL for the first wash, 250 μL for the second wash, and 50 μL for the final 
wash—all samples were centrifuged at 2,000 × g for 1 minute for every subsequent wash to remove 
the buffer. Afterwards, the samples were centrifuged at 16,900 × g for 1 minute to remove any 
residual ethanol. Finally, 50 μL of column elution buffer (2.5 mM Tris-HCl, 0.1 mM EDTA, [pH 
8.0]) were transferred to the center of each column; purified products were allowed to incubate at 




Purified products were ligated by incubating a 10 μL mixture containing 1× T4 DNA ligase 
reaction buffer, 8 μL of PCR product, and 0.4 μL of T4 DNA Ligase (400,000 U/mL) at room 
temperature for 10 minutes. After ligation, mutant plasmids were transformed into E. coli strain 
NEB 5-α. Briefly, NEB 5-α was streaked onto an LB plate and incubated overnight at 37 °C. A 
single colony was selected and used to inoculate a 1 mL starter culture composed of LB and 0.2% 
glucose which aerobically grew overnight at 37 °C. Starter cultures were diluted 1:100 into several 
1 mL broths containing LB and 0.2% glucose and allowed to grow for 2 hours at 37 °C. After 
reaching mid-exponential phase, cultures were harvested at 5,000 × g for 3 minutes. After 
discarding media, pellets were resuspended in 100 μL Transformation and Storage Solution (TSS, 
10% polyethylene glycol 8000, 30 mM MgCl2, 5% dimethyl sulfoxide, 0.2% glucose, dissolved 
in LB), and 40 μL of resuspended cells were transferred to pre-chilled 1.7 mL microcentrifuge 
tubes [60]. Five microliters of each ligated PCR product were transferred to their respective 40 μL 
mixtures to begin transformation. Competent cells were incubated on ice for 10 minutes, at room 
temperature for 10 minutes, and finally on ice again for an additional 10 minutes to allow for 
transformation of ligated products. One milliliter of LB with 0.2% glucose was added to each 
transformant tube, and all tubes were incubated at 37 °C for 1 hour to allow for cell recovery. 
Recovered cells were harvested at 5,000 × g for 3 minutes, and ~900 μL of supernatant were 
discarded. Pellets were resuspended with the remaining ~100 μL of supernatant and transferred to 




Plasmid Preparation and Sequencing 
Several transformant colonies were selected for minipreps via inoculation of several 2 mL 
LB broths which were cultured overnight at 37 °C. Cells from each overnight culture were 
harvested at 7,000 × g for 5 minutes, resuspended with 200 μL of cell resuspension buffer (50 mM 
Tris-HCl, 10 mM EDTA, 50 μg/mL RNase A, [pH 8.0]), and vortexed thoroughly to remove cell 
clumps. Afterwards, 250 μL of cell lysis solution (0.2 M NaOH, 1% sodium dodecyl sulfate) were 
added to resuspended cells, and the mixture was inverted several times and incubated at room 
temperature for 5 minutes to allow for cell lysis. To begin removing genomic DNA and protein, 
350 μL of neutralization buffer (4 M guanidinium-HCl, 0.5 M potassium acetate, [pH 4.2]) were 
added to each lysate; all lysates were inverted several times before being centrifuged at 16,900 × 
g for 10 minutes. The supernatants were transferred to DNA Mini-Spin Columns and centrifuged 
twice at 2,000 × g for 1 minute to bind the target plasmids. Columns were washed with 300 μL of 
guanidine wash buffer (5 M guanidinium-HCl, 20 mM Bis-Tris-HCl, 33% ethanol, [pH 6.5]) and 
centrifuged at 2,000 × g for 1 minute. As described earlier, samples were additionally washed with 
column wash buffer three times at decreasing volumes per wash: 400 μL for the first wash, 225 
μL for the second wash, and 75 μL for the final wash—all samples were centrifuged at 2,000 × g 
for 1 minute for every subsequent wash to remove the buffer. Samples were centrifuged at 16,900 
× g for 1 minute to remove all traces of ethanol. Finally, as described earlier, 50 μL of column 
elution buffer were added to the center of each spin column—samples incubated at room 




Mutations were confirmed by Sanger sequencing provided by GENEWIZ—
chromatograms were generated using the sequencing data and visibly inspected using SnapGene 
Viewer (GSL Biotech). Upon confirmation of each mutation, all plasmids were transformed into 
E. coli strain Lemo21(DE3). Briefly, Lemo21(DE3) was streaked onto an LB plate supplemented 
with 34 μg/mL chloramphenicol and incubated overnight at 37 °C. A single colony was used to 
inoculate a 1 mL starter culture containing LB supplemented with 0.2% glucose and 34 μg/mL 
chloramphenicol which was allowed to aerobically incubate overnight at 37 °C. The starter culture 
was diluted 1:100 into several 1 mL broths containing identical media and grew for 2 hours at 37 
°C. The TSS method as described earlier was used to transform the plasmids into Lemo21(DE3). 
After cell recovery and harvesting, 100 μL of competent cells were plated on LB agar 
supplemented with 100 μg/mL ampicillin and 34 μg/mL chloramphenicol and incubated overnight 
at 37 °C. Single transformant colonies were used to make 15% glycerol stocks which were stored 
at -80 °C. 
Expression and Purification of SclA Mutants 
Wild-type (WT) SclA and mutants were overexpressed in E. coli strain Lemo21(DE3) and 
purified using N-terminal His6-tags. Unless stated otherwise, the following procedure was used for 
overexpression and purification of WT and all mutants mentioned in this study. Glycerol stocks of 
these strains were streaked onto modified LB agar and incubated overnight at 37 °C. Pure colonies 
were used to inoculate 50 mL starter cultures which were allowed to shake overnight at 37 °C. 
Starter cultures were diluted 1:100 into 4 liter (2 × 2 liter) overexpression cultures which were 
allowed to grow for 1.5 hours at 37 °C. The temperature was then immediately shifted to 25 °C 
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and allowed to equilibrate for an additional 20 minutes. After equilibration, the cultures were 
induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 7 hours. Cultures were 
immediately placed on ice, transferred to pre-chilled 1-liter centrifuge bottles, and harvested at 
12,000 × g for 10 minutes at 4 °C using a Sorvall RC6+ centrifuge—this device was used for all 
harvest and clarification steps unless otherwise stated. Cell pellets were resuspended with 25 mL 
of cold cell wash buffer (25 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, [pH 8.0]), harvested as 
stated before, and stored at -80 °C.  
Before lysis, cells were thawed at 4 °C, resuspended in 80 mL of cold lysis buffer (25 mM 
Tris-HCl, 300 mM NaCl, 0.05% Tween-20, 5% glycerol, [pH 8.0]) supplemented with 1 mM 
benzamidine, and vortexed for 1 minute. One microliter of Pierce Universal Nuclease for Cell 
Lysis (250 U/μL) was added to the diluted suspension to digest any remaining nucleic acids. The 
suspension was passed through a French Press with a pre-chilled Manual-Fill 40K Cell three times 
at maximum standard pressure (40,000 psi) to completely lyse the cells. All centrifugation and 
purification steps were carried out at 4 °C. The crude lysate was clarified at 28,900 × g for 20 
minutes. From this point onward, all centrifugation steps regarding resin harvest were carried out 
using a Hermle Z400K centrifuge. Two milliliters of HisPur Cobalt Resin were washed with 20 
mL of cobalt binding buffer (25 mM Tris-HCl, 300 mM NaCl, 5 mM imidazole, 0.05% Tween-
20, 14 mM β-mercaptoethanol [β-Me], 5% glycerol, [pH 8.0]) and centrifuged at 1,000 × g for 5 
minutes. After decanting the supernatant, the washed resin was mixed with the soluble lysate in a 
50 mL conical tube and allowed to batch-bind via end over end rotation for 1 hour at 4 °C. The 
mixture was centrifuged at 1,000 × g for 5 minutes to collect the protein-bound resin. From here 
on out, the Bradford assay was utilized to track the protein across the purification by sampling 5 
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μL from each step and adding to 100 μL of 1× Bradford reagent in a 96-well plate [61]. Resin was 
resuspended with cobalt binding buffer, transferred to a gravity column, and pre-washed with 
cobalt wash buffer (25 mM Tris-HCl, 300 mM NaCl, 20 mM imidazole, 0.05% Tween-20, 14 mM 
β-Me, 5% glycerol, [pH 8.0]) at 75% of the bed volume. Afterwards, the resin was washed with 6 
bed volumes of cobalt wash buffer at least 4 times. To dilute the wash buffer, the resin was then 
pre-eluted with cobalt elution buffer (25 mM Tris-HCl, 300 mM NaCl, 250 mM imidazole, 0.05% 
Tween-20, 14 mM β-Me, 5% glycerol, [pH 8.0]) at 75% of the bed volume. Afterwards, the target 
protein was eluted with 2 bed volumes of cobalt elution buffer at least 4 times. Once cobalt affinity 
was completed, 1 mL of Q Sepharose Fast Flow resin was washed with 20 mL of Q binding buffer 
(12.5 mM Tris-HCl, 50 mM NaCl, 0.05% Tween-20, 14 mM β-Me, 5% glycerol, 0.1 mM EDTA, 
[pH 8.0]). Elutions were pooled together and mixed with Q resin; to dilute the imidazole, the total 
volume of the binding mixture was brought up to 40 mL with deionized water (dH2O). Protein was 
allowed to bind for 15 minutes in the cold as described earlier. Protein-bound resin was harvested 
via centrifugation at 1,000 × g for 5 minutes. Resin was resuspended with Q binding buffer, 
transferred to a gravity column, and pre-washed with Q wash buffer (12.5 mM Tris-HCl, 100 mM 
NaCl, 0.05% Tween-20, 14 mM β-Me, 5% glycerol, 0.1 mM EDTA, [pH 8.0]) at 75% of the bed 
volume. Two bed volumes of Q wash buffer were used to wash the resin at least 2 times. To dilute 
the wash buffer, the resin was pre-eluted with Q elution buffer (12.5 mM Tris-HCl, 500 mM NaCl, 
0.05% Tween-20, 14 mM β-Me, 5% glycerol, 0.1 mM EDTA, [pH 8.0]) at 75% of the bed volume. 
Afterwards, protein was eluted with 1 bed volume of Q elution buffer at least 6 times. Elutions 
were pooled together and dialyzed against 1 liter of storage buffer (50 mM HEPES-KOH, 5% 
glycerol, [pH 7.5]) overnight at 4 °C.  
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Protein Analysis and Quantification 
Induction and purification of all proteins were analyzed via sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) [62]. To assess the induction of each protein, 1 
mL samples of the overexpression cultures were taken before and after full protein induction. The 
sample before addition of IPTG was labeled “pre-IPTG” while the sample after full induction was 
labeled “post-IPTG”. The optical densities at 600 nm (OD600) of each sample were analyzed using 
an Agilent 8453 UV-visible spectrophotometer. The OD600 of the post-IPTG sample was 
normalized to the OD600 of the pre-IPTG sample. Both samples were harvested at 12,000 × g for 
5 minutes using an Eppendorf 5418 centrifuge. After decanting media, pellets were stored at -80 
°C. For sample preparation of induction pellets, 40 μL of 2× Laemmli sample buffer were used to 
resuspend the cells before lysing via incubation at 100 °C in a sand bath for 5 minutes. For general 
sample preparation, 8 μL were pulled from all steps of the purification scheme, mixed with 32 μL 
of 2× Laemmli sample buffer, and heated similarly for 5 minutes. Five microliters of boiled 
samples were routinely loaded on 12% Tris-glycine gels and electrophoresed at 35 mA for 1 hour. 
Gels were gently washed with dH2O for 5 minutes before replacing the water with a gel staining 
solution (0.02% Coomassie Brilliant Blue G-250, 10% methanol, 10% acetate) and microwaving 
until the staining solution began to boil. After initial staining, gels were agitated on a low-speed 
orbital shaker for 10 minutes before replacing staining solution with 10% acetate for destaining. 
To accelerate the destaining process, the solution was microwaved to a boil, then Kimwipes were 
added while the gels were allowed to agitate as before. Gels with clear backgrounds were deemed 
ready for imaging. Destained gels were gently washed with dH2O before being analyzed with a 
ChemiDoc MP Imaging System. 
19 
 
Protein concentrations of dialyzed enzymes were quantified via their absorbance profiles 
at 280 nm. Briefly, samples were diluted 1:10 in 6 M guanidinium-HCl and read using an Agilent 
8453 UV-visible spectrophotometer. The predicted molecular weight and theoretical molar 
absorptivity coefficient of SclA at 280 nm were 41,525.86 Da and 39,420 M-1 cm-1 respectively, 
as determined by the ProtParam tool by ExPASy [63]. Beer’s law was used to calculate protein 
concentration [64]. Proteins were stored in 400 μL aliquots at -20 °C. 
Lead Acetate Assay 
The SCL activities of all purified proteins were analyzed with the lead acetate assay [37]. 
Upon addition of lead acetate, any hydrogen selenide (H2Se) present reacts to form lead selenide 
(PbSe) which can be detected at 400 nm. The assay was carried out in a 96-well plate format. The 
assay mixture was formulated containing the following reagents: 50 mM HEPES-KOH (pH 7.5), 
5 mM dithiothreitol (DTT), 0.2 mM PLP, 1 mM pyruvate, and 0.02 mM EDTA. The substrate was 
prepared by first dissolving the oxidized form, L-selenocystine, with NaOH at a 1:1 molar ratio of 
L-selenocysteine-to-NaOH—the diselenide molecule is automatically reduced by DTT to L-
selenocysteine in the assay. An enzyme mixture was prepared containing 0.3 mg/mL SclA and 0.8 
mg/mL bovine serum albumin (BSA); from this mix, 5 μL were added to 90 μL of 1× assay 
mixture. To begin the enzymatic reaction, 5 μL of L-selenocystine were added to the above mixture 
for a final volume of 100 μL. The assay was carried out in triplicate at 25 °C for various lengths 
of time to ascertain the initial rates of HSe- production at varying substrate concentrations. Enzyme 
was omitted in a blank as a negative control. Reactions were quenched with 100 μL of 5 mM lead 
acetate dissolved in 0.5 M HCl. The optical densities at 400 nm of 200 μL quenched samples were 
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analyzed with a SpectraMax 190 Microplate Reader. The molar turbidity coefficient of PbSe at 
400 nm is 1.18 × 104 M-1 cm-1 and was used to calculate the HSe
- concentration via Beer’s law [35, 
64]. Blank rates were averaged and subtracted from sample rates. Rates were fit to the Michaelis-
Menten equation using GraphPad Prism 8. For inhibition studies, several solutions of 1× assay 
mixture were supplemented with 0.25 mM, 0.5 mM, 0.75 mM, and 1 mM L-cysteine. For 
inhibition assays, rates were transformed to generate double-reciprocal plots; after inspection of 
the trendlines in these plots, rates were fit to a competitive inhibition model using GraphPad Prism 
8. All kinetic parameters and standard deviations were calculated using GraphPad Prism 8. 
Methylene Blue Assay 
The CDS activities of all purified proteins were analyzed with the methylene blue assay 
[65]. Upon addition of N,N-dimethyl-p-phenylenediamine (DPD) and FeCl3, any hydrogen sulfide 
(H2S) present reacts to form methylene blue which can be detected at 650 nm. The assay was 
carried out in a 96-well plate format. The assay mixture was formulated containing the following 
reagents: 50 mM HEPES-KOH (pH 7.5), 5 mM DTT, 0.2 mM PLP, 1 mM pyruvate, and 0.02 mM 
EDTA. Two enzyme mixtures supplemented with 0.16 mg/mL BSA were prepared containing 
0.06 mg/mL SclA and 0.4 mg/mL SclA; from these mixes, 25 μL were added to 50 μL of 2× assay 
mixture. To begin the enzymatic reaction, 25 μL of 1 mM L-cysteine were added to the above 
mixture for a final volume of 100 μL. The assay was carried out in triplicate at 25 °C for various 
lengths of time to determine HS- production. Enzyme was omitted in a blank as a negative control. 
Reactions were quenched with 10 μL of 20 mM DPD dissolved in 7.2 M HCl and 10 μL of 30 mM 
FeCl3 dissolved in 1.2 M HCl. Samples were allowed to incubate at 25 °C for 10 minutes for color 
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development. The absorbances at 650 nm of 120 μL quenched samples were analyzed with a 
SpectraMax 190 Microplate Reader. A standard curve with Na2S was generated to determine HS
- 





CHAPTER 3: RESULTS 
H100 of SclA aligns to D146 of hSCL 
It is already known that the selenocysteine specificity of hSCL is strongly governed by one 
active site residue: D146 [50, 51]. With this in mind, we wondered if this “single-residue” property 
held true in a previously characterized bacterial SCL: SclA. To search for putative specificity-
determining residues in SclA, we generated a multiple sequence alignment with various 
characterized NifS-like proteins using Clustal Omega (Figure 1). According to the alignment, 
H100 appeared to directly align with D146, implying that H100 may likewise function as a 
determinant for selenium-over-sulfur discrimination. Furthermore, various conserved regions were 
shared throughout the protein sequences including the catalytic cysteines, PLP-binding lysines, 
and group I and II bacterial NifS-like consensus sequences. In the case of SclA, the presence of 
the RXGXHCA consensus sequence in the active site confirms its identity as a group II bacterial 
NifS-like protein [32, 34]. These aligned regions further added confidence to the hypothesis that 
H100 may function similarly to D146. 
After the initial sequence alignment, we were interested in comparing the structural 
positions of D146 and H100—while the former is a verified catalytic residue in the active site, the 
location of the latter is unknown. To further investigate the potential role of H100 as a specificity-
determining residue and probe the structural question, we generated three-dimensional models of 
SclA and hSCL using PyMOL. While hSCL could easily be modeled due to already possessing a 
known crystal structure, there was greater difficulty in modeling SclA since it lacked one; thus, 
we used SWISS-MODEL to search for closely related structural homologs of SclA. The top result 
was SufS from B. subtilis which shared 36.99% sequence identity with the E. faecalis enzyme; 
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furthermore, a crystal structure of SufS had been determined in a previous study [66]. With 
SWISS-MODEL, we threaded the primary sequence of SclA through SufS, generated a putative 
3-D structure, and further modeled it using PyMOL. The results of both homology models are 
shown in Figure 2. Fortunately, the model of WT hSCL highly resembled its crystal structure, 
containing the conserved NifS-like residues—the PLP-bound K259 and catalytic C388—in its 
active site (Figure 2A). Another conserved residue, H145, was located nearby the PLP molecule 
and C388, implying a role in catalysis. Finally, D146 was found within 4 angstroms of C388, as 
predicted by the crystal structure [50]. Additionally, Figure 2B shows the predicted active site of 
hSCL with a D146K mutation, visualizing the difference in charge. In Figure 2C, the predicted 
active site of WT SclA contained the following conserved NifS-like residues: K202 and C341. 
Because this structure is purely hypothetical, PLP could not be modeled bound to K202 like it was 
bound to K259 of hSCL, having already been present in the crystal structure. The residue that 
aligns to H145 from hSCL in SclA, H99, appeared to likewise position itself next to C341. 
Furthermore, H100 also seemed to occupy a position away from the cluster of residues similar to 
D146 of hSCL. The configuration of these residues in SclA (Figure 2C) seems to spatially mimic 
the configuration in hSCL (Figure 2A). While the bacterial model is strictly putative, these data 






Figure 1: Sequence alignment of SclA and other NifS-like proteins 
NifS-like protein sequences from several organisms were aligned using Clustal Omega [55]. 
Smaller segments of the alignment were selected to highlight relevant residues. The arrow 
indicates the alignment of D146 of human SCL (green) to H100 of E. faecalis SclA (blue). The 
core catalytic cysteine residue is highlighted in red while the PLP-binding lysine residue is 
highlighted in purple. The consensus sequences for group I (SSGSACTS) and group II 
(RXGXHCA) bacterial NifS-like proteins are shaded in gray [32, 34]. Fully conserved residues 
are indicated by asterisks (*). Partially conserved residues are indicated by colons (:) for residues 






Figure 2: The modeled structure of SclA is similar to the defined hSCL active site 
3-D structures of human SCL and SclA were modeled using PyMOL [56]. The primary sequence 
of SclA was threaded through the established crystal structure of B. subtilis SufS as a template to 
create a homology model using SWISS-MODEL [57]. (A) Active site of WT human SCL as 
determined by X-ray crystallography [50]. (B) Active site of human SCL with a D146K mutation. 
(C) Putative active site of WT SclA, (D) SclA H100K, (E) SclA H100D, (F) SclA H100A, and 





H100 point mutants of SclA were successfully generated 
Since a D146K mutation in hSCL resulted in the appearance of CDS activity, we 
hypothesized that a mutation of H100 would influence SclA in a similar manner. To begin probing 
this question, H100 was mutated to several amino acid residues of differing character (H100K, 
H100D, H100A, and H100N) via ‘Round-the-horn site-directed mutagenesis; these mutations 
were selected to ascertain the substrate specificity and catalytic influence of basic, acidic, 
nonpolar, and polar uncharged properties, respectively. An ethidium bromide agarose gel 
showcasing the individual ~6.9 kb PCR products after mutagenesis is shown in Figure 3A, clearly 
demonstrating successful PCRs and product purity. These PCR products were gel-extracted, 
ligated, and transformed into E. coli strain NEB 5-α which was then utilized for plasmid minipreps. 
To confirm the presence of each mutation, the mutant plasmid minipreps were sequenced (Figure 
3B). The sequencing chromatograms for WT and all mutants revealed well-defined signal peaks 
with minimal background noise and clear distinction between the base calls, indicating the purity 






Figure 3: Site-directed mutagenesis of SclA 
The plasmid containing sclA (EF2568), pRT1, was subjected to ‘Round-the-horn site-directed 
mutagenesis in order to generate several H100 point mutants [58, 59]. Primers for each PCR are 
listed in Table 1. (A) Ethidium bromide agarose gel displaying PCR products of each mutagenesis. 
(B) Sequencing chromatograms of regions of interest from each sequenced plasmid. Target codons 
are underlined. Signal peaks indicate sequenced bases and sample purity. Chromatograms were 






SclA H100 mutants can be overexpressed and purified 
Before beginning to answer the substrate specificity question regarding H100, pure soluble 
forms of each mutant enzyme needed to be obtained. To achieve this goal, mutant plasmids were 
transformed into E. coli strain Lemo21(DE3). All proteins were overexpressed and purified in the 
same manner as described in Materials and Methods. Thus, Figures 4A, 4B, and 4C were included 
to showcase only the H100K purification as an example and avoid redundancy. In Figure 4A, a 
relatively sizable ~42 kDa band corresponding to the theoretical weight of SclA appeared after 
induction with IPTG, indicating that SclA can be overexpressed heterologously; moreover, 
successful induction of the target protein further confirmed the results of the earlier transformation. 
Additionally, the protein seemed to present mostly within the insoluble fraction even after a 7-
hour induction at 25 °C with 0.5 mM IPTG. Nevertheless, the amount of target protein in the 
soluble lysate was sufficient for purification and downstream experiments. Initially, cobalt affinity 
chromatography was used to capture SclA from the lysate, successfully eliminating most of the E. 
coli contaminants with 5 mM imidazole in the batch-binding step and 20 mM imidazole in 
subsequent washes (Figure 4B). Contaminants with molecular weights lower than ~40 kDa co-
eluted with the target protein—the banding pattern implies either proteolytic degradation or N-
terminal truncation since all mutants were N-terminally His6-tagged. Finally, anion exchange 
chromatography was used as a polishing step to rid the target protein of any lingering contaminants 
that were not removed with moderate amounts of imidazole (Figure 4C). After purification was 
completed, elutions were pooled together, dialyzed, and inspected on an SDS-PAGE gel (Figure 
4D). All results described for purification of this mutant were comparable for all other 
purifications; all mutants in Figure 4D were determined to be pure for downstream 
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experimentation. Overall, these results demonstrate that SclA and selected point mutants can be 
overexpressed and purified to homogeneity for future studies; additionally, because the H100 
mutants could be purified from the soluble lysates, it stands to reason that H100 does not seem to 






Figure 4: Purification scheme and purity of SclA and mutant proteins 
SclA and several mutants were overexpressed in E. coli and purified with cobalt affinity and anion 
exchange column chromatography. The results are shown here via Coomassie-stained SDS-PAGE 
gels. For further details, see Materials and Methods. As an example of the purification scheme, 
gels from the H100K purification are shown in panels A-C. (A) Gel tracking protein induction, 
cell lysis, and pooled elutions from each chromatographic step. Co++ and Q elutions were pooled 
from their respective steps in panels B and C. (B) Gel demonstrating the cobalt affinity 
chromatographic step. (C) Gel demonstrating the subsequent anion exchange chromatographic 
step. (D) Gel showcasing the relative purity of all pooled enzymes after their respective 





SclA H100 mutants demonstrate varying Michaelis-Menten kinetics for L-selenocysteine 
To ascertain the effects of H100 mutations on substrate specificity, purified proteins were 
assayed for SCL activity using the lead acetate assay. Because other NifS-like enzymes report the 
formation of a persulfide linkage between the sulfur atom and the catalytic cysteine, a similar 
mechanism may be happening in SCLs [49]. In SCLs, HSe- may not be the “true” product of the 
reaction; rather, the selenium atom may be linked to the catalytic cysteine through a selenosulfide 
bond similar to CDSs. In order to break this bond and release the selenium, a strong reductant like 
DTT must be used. Moreover, HSe- can only be detected spectrophotometrically if reduced to 
H2Se and complexed with lead, forming PbSe which is observable at 400 nm; thus, the catalytic 
activity of SclA can be analyzed with the lead acetate assay in order to determine the kinetics of 
its SCL activity. Figures 5 through 9 reveal the SCL activities of WT SclA and its H100 point 
mutants.  
A thorough investigation of each enzyme revealed that they all exhibited Michaelis-Menten 
kinetics for L-selenocysteine at varying levels relative to each other. The kinetic parameters of 
each mutant (including standard deviations) are catalogued in Table 2. WT SclA exhibited a Km
app 
of 3.55 ± 0.32 mM for L-selenocysteine (Figure 5) with H100K and H100N indicating similar 
values of 3.71 ± 0.17 mM (Figure 6) and 3.38 ± 0.26 mM (Figure 9), respectively. Curiously, 
H100D displayed the weakest affinity for L-selenocysteine, showcasing a Km
app of 5.02 ± 0.49 mM 
(Figure 7); conversely, H100A demonstrated the strongest affinity for L-selenocysteine with a 
Km
app of 1.86 ± 0.13 mM (Figure 8). Furthermore, H100K and H100N exhibited the highest Vmax
app 
values of 8.34 ± 0.13 μmol min-1 mg-1 and 9.89 ± 0.25 μmol min-1 mg-1 while WT, H100D, and 
H100A had lower values that were all relatively similar. Though H100K and H100N exhibited the 
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highest significant turnover numbers (kcat) of 5.79 ± 0.09 s
-1 and 6.86 ± 0.17 s-1 respectively, the 
most catalytically efficient (kcat/Km
app) enzymes were H100A with a value of 2.44 s-1 mM-1 and 
H100N with the value of 2.03 s-1 mM-1 (Table 2). While H100N exhibited faster turnover, the 
higher binding affinity for L-selenocysteine in H100A heavily contributed to its catalytic 
efficiency. However, all significant kinetic differences regarding Km
app, Vmax
app, kcat, and kcat/Km
app 
due to H100 mutations only resulted in <2-fold changes compared to WT.  
It is worth noting that some enzymes displayed substrate inhibition at concentrations above 
10 mM L-selenocysteine. The enzymes that experienced substrate inhibition were WT, H100D, 
and H100A. Because this non-Michaelis-Menten phenomenon skewed the Michaelis-Menten 
parameters of the data sets, these inhibitory concentrations were omitted from their respective 
figures. Altogether, the kinetic variance in each mutant confirms that H100 is in the active site of 






Figure 5: SclA exhibits Michaelis-Menten kinetics with L-selenocysteine as a substrate 
The selenocysteine lyase kinetics of purified WT SclA were determined using the lead acetate 
assay. The saturation curve was generated by fitting initial rates (V0) to the Michaelis-Menten 
equation using GraphPad Prism 8. Kinetic parameters provided below the curve are described 
further in Table 2. Vmax
app is indicated by a dotted asymptote drawn on the y-axis. Data points 






Figure 6: H100K exhibits faster turnover with similar affinity for L-selenocysteine 
The selenocysteine lyase kinetics of purified SclA H100K were determined using the lead acetate 
assay. The saturation curve was generated by fitting initial rates (V0) to the Michaelis-Menten 
equation using GraphPad Prism 8. Kinetic parameters provided below the curve are described 
further in Table 2. Vmax






Figure 7: H100D exhibits the weakest affinity for L-selenocysteine 
The selenocysteine lyase kinetics of purified SclA H100D were determined using the lead acetate 
assay. The saturation curve was generated by fitting initial rates (V0) to the Michaelis-Menten 
equation using GraphPad Prism 8. Kinetic parameters provided below the curve are described 
further in Table 2. Vmax
app is indicated by a dotted asymptote drawn on the y-axis. Data points 






Figure 8: H100A exhibits the strongest affinity for L-selenocysteine 
The selenocysteine lyase kinetics of purified SclA H100A were determined using the lead acetate 
assay. The saturation curve was generated by fitting initial rates (V0) to the Michaelis-Menten 
equation using GraphPad Prism 8. Kinetic parameters provided below the curve are described 
further in Table 2. Vmax
app is indicated by a dotted asymptote drawn on the y-axis. Data points 






Figure 9: H100N exhibits the fastest turnover for L-selenocysteine 
The selenocysteine lyase kinetics of purified SclA H100N were determined using the lead acetate 
assay. The saturation curve was generated by fitting initial rates (V0) to the Michaelis-Menten 
equation using GraphPad Prism 8. Kinetic parameters provided below the curve are described 
further in Table 2. Vmax





L-Cysteine inhibits the SCL activities of H100 mutants 
It is known that L-cysteine acts as an SCL inhibitor [37-39]. To determine the effect of L-
cysteine on the SCL activity of the bacterial enzyme, the lead acetate assay was repeated with 
several concentrations of L-cysteine for WT and all mutants. Because the assay is costly to run, 
only four concentrations of L-selenocysteine and L-cysteine were chosen; two concentrations of 
substrate above and below the Km
app values of each enzyme were selected while L-cysteine 
concentrations of 0.25 mM, 0.5 mM, 0.75 mM, and 1 mM were decided upon. Double-reciprocal 
plots were generated from the initial rates of HSe- formation to determine the type of inhibition 
mediated by L-cysteine (Figures 10-14). Upon visible inspection of the double-reciprocal plot for 
WT, L-cysteine seems to act as a competitive inhibitor due to the fact that the trendlines appear to 
roughly converge on a single point above the x-axis while the slopes change with each varying 
condition, resulting in varying x-intercepts (Figure 10). Thus, the Vmax
app does not appear to change 
while the Km
app changes significantly upon L-cysteine titration, indicating competitive inhibition. 
While this effect differs slightly with each mutant, the overall trend appears to be the same.  
To determine the Ki
app values of each mutant, the same rates were fit with a competitive 
inhibition model in GraphPad Prism 8—the values and calculated error (standard deviation) are 
listed in Table 2. WT exhibited a Ki
app of 0.55 ± 0.09 mM for L-cysteine (Figure 10) while H100D 
and H100N exhibited similar values of 0.62 ± 0.07 mM (Figure 12) and 0.57 ± mM (Figure 14). 
Curiously enough, H100K demonstrated the weakest affinity for inhibitor with a Ki
app of 1.24 ± 
0.15 mM which accounted for a ~2.3-fold increase compared to WT (Figure 11). On the other 
hand, H100A demonstrated the strongest affinity with a value of 0.39 ± 0.05 mM (Figure 13). 
Accounting for standard deviation, the Ki
app for H100A was only slightly different from WT (~1.4-
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fold decrease in Ki
app), so the actual significance of this value may be unclear. Strangely, all Ki
app 
parameters were well below all reported Km
app values in this study, implying that L-cysteine binds 
substantially better to the enzyme compared to its primary substrate, L-selenocysteine. Overall, 
the variance in competitive inhibitory data further supports the notion that H100 influences 






Figure 10: SclA’s selenocysteine lyase activity is inhibited by L-cysteine in a competitive 
manner 
The selenocysteine lyase activities of purified WT SclA in the presence of increasing 
concentrations of L-cysteine were determined by the lead acetate assay. Four concentrations of L-
selenocysteine (two above and below the Km
app) were utilized. Double-reciprocal plots were 
generated from initial rates (V0) using the Lineweaver-Burk model in GraphPad Prism 8. Ki
app and 
standard deviation values were calculated by fitting initial rates to the competitive inhibition model 
in the same program. Error bars indicate standard deviation; error bars smaller than the data points 






Figure 11: H100K exhibits the weakest affinity for L-cysteine as an inhibitor 
The selenocysteine lyase activities of purified SclA H100K in the presence of increasing 
concentrations of L-cysteine were determined by the lead acetate assay. Four concentrations of L-
selenocysteine (two above and below the Km
app) were utilized. Double-reciprocal plots were 
generated from initial rates (V0) using the Lineweaver-Burk model in GraphPad Prism 8. Ki
app and 
standard deviation values were calculated by fitting initial rates to the competitive inhibition model 
in the same program. Error bars indicate standard deviation; error bars smaller than the data points 






Figure 12: H100D exhibits no significant change in inhibition by L-cysteine 
The selenocysteine lyase activities of purified SclA H100D in the presence of increasing 
concentrations of L-cysteine were determined by the lead acetate assay. Four concentrations of L-
selenocysteine (two above and below the Km
app) were utilized. Double-reciprocal plots were 
generated from initial rates (V0) using the Lineweaver-Burk model in GraphPad Prism 8. Ki
app and 
standard deviation values were calculated by fitting initial rates to the competitive inhibition model 
in the same program. Error bars indicate standard deviation; error bars smaller than the data points 






Figure 13: H100A exhibits the highest affinity for L-cysteine as an inhibitor 
The selenocysteine lyase activities of purified SclA H100A in the presence of increasing 
concentrations of L-cysteine were determined by the lead acetate assay. Four concentrations of L-
selenocysteine (two above and below the Km
app) were utilized. Double-reciprocal plots were 
generated from initial rates (V0) using the Lineweaver-Burk model in GraphPad Prism 8. Ki
app and 
standard deviation values were calculated by fitting initial rates to the competitive inhibition model 
in the same program. Error bars indicate standard deviation; error bars smaller than the data points 






Figure 14: H100N exhibits no significant change in inhibition by L-cysteine 
The selenocysteine lyase activities of purified SclA H100N in the presence of increasing 
concentrations of L-cysteine were determined by the lead acetate assay. Four concentrations of L-
selenocysteine (two above and below the Km
app) were utilized. Double-reciprocal plots were 
generated from initial rates (V0) using the Lineweaver-Burk model in GraphPad Prism 8. Ki
app and 
standard deviation values were calculated by fitting initial rates to the competitive inhibition model 
in the same program. Error bars indicate standard deviation; error bars smaller than the data points 





SclA demonstrates weak CDS activity 
Because L-cysteine, an inhibitor, bound to SclA and its mutants with higher affinity than 
its primary substrate, L-selenocysteine, we began to ponder whether SclA might act on L-cysteine 
if substantial amounts of protein were used in the assay. The methylene blue assay was used to 
determine if SclA could generate HS- from L-cysteine. Briefly, if HS- is generated by a NifS-like 
protein, it is reduced to H2S by a strong reductant and then, upon the addition of DPD and FeCl3, 
converted to methylene blue which is detectable at 650 nm. Using the same amount of enzyme (15 
μg/mL, 0.36 μM) as the lead acetate assay and 1 mM L-cysteine, we observed no significant 
absorbance change over time (Figure 15A). While it seemed like H100K, H100A, and H100N 
were slowly evolving more HS- than WT and H100D, the signal-to-noise ratios were so miniscule 
that they could have been mistaken for background noise. To verify if the absorbance changes 
were due to weak signals, 100 μg/mL (2.4 μM) of enzyme were added to probe whether very small 
amounts of product might be detected. Repeating the assay with this amount of enzyme revealed 
that all mutants including the WT generated a significant amount of HS- within the observed 
timeframe, implying that SclA already possesses extremely poor CDS activity (Figure 15B). 
Because this activity was so weak compared to SCL activity, HS- concentrations could not be 
derived from sample absorbances because they were well below the linear range of the Na2S 
standard curve. While all reactions were determined at 1 mM L-cysteine, HS- rates seemed to differ 






Figure 15: SclA and mutants demonstrate poor cysteine desulfurase activity 
The CDS activities of purified SclA and H100 mutants were determined by the methylene blue 
assay with 1 mM L-cysteine. Data points were fit with a linear regression using GraphPad Prism 
8. Error bars indicate standard deviation; error bars smaller than the data points are not shown. (A) 
Reaction progress curve of sulfide production with 15 μg/mL (0.36 μM) enzyme. (B) Reaction 





CHAPTER 4: DISCUSSION 
Manipulation of the catalytic cysteine may provide specificity 
In this work, we further characterized the substrate specificity of SclA by investigating its 
enzyme kinetics after mutation of a putative active site residue: H100. Without a crystal structure, 
it is difficult to draw conclusions concerning the catalytic residues in the active site of SclA, but 
the alignment and homology models shown earlier can function as guides for analysis. It is also 
important to note that the pKa of the catalytic cysteine, C341, is yet unknown. In water-based 
solutions, free cysteine has a pKa of ~8.5, resulting in mostly protonated and unreactive thiol groups 
at physiological pH. However, this is not always the case within the active site of a protein where 
catalytic cysteine residues are comparatively more reactive due to acidic pKa values. The active 
site microenvironment of a protein contains clusters of differently-charged amino acid residues 
that greatly influence the pKa values of catalytic cysteines—in this case, a lowering of the pKa 
results in deprotonation to the reactive thiolate species at physiological pH. As stated earlier, CDSs 
contain a conserved reactive thiolate which non-specifically attacks sulfur or selenium, depending 
on the substrate [49]. On the other hand, SCLs are implied to contain a thiol group rather than a 
thiolate, thereby limiting its reactivity to only L-selenocysteine rather than L-cysteine. It has been 
hypothesized that L-selenocysteine likely deprotonates the thiol to a thiolate which could then 
attack the electrophilic substrate—as stated earlier, L-cysteine does not exhibit this type of 
biochemical reactivity at physiological pH [51]. In hSCL, D146 may have destabilized this thiolate 
group, restricting it to the protonated species [50, 51]. Thus, it would stand to reason that the 
specificity of SCLs most likely lies within controlling the protonation state of the catalytic cysteine 
via nearby residues. Perhaps this may also occur in SclA. 
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H100 may not function as a catalytic residue 
In SclA, the function of H100 is still unclear. The significant changes in HSe- kinetics from 
each mutant implied that it played a role in catalysis; the positively-charged imidazolium group of 
histidine would probably act as a general base to abstract the hydrogen atom from C341’s thiol 
group. However, while the changes in kinetics amongst enzymes were significant, the differences 
in turnover and catalytic efficiency were only slight (<2.0-fold differences in both kcat and 
kcat/Km
app). Therefore, H100 may not act as a base for catalysis; it may just only influence the pKa 
of the thiol in a minor fashion. Additionally, because selenocysteine is a potent nucleophile, it 
most likely abstracts the thiol’s proton in the first place, rendering any other base catalysis 
unnecessary and allowing specificity over cysteine—this may also explain why the H100 mutants 
were still able to react with L-selenocysteine. 
SclA binds L-cysteine better than L-selenocysteine 
The inhibition of SCLs by L-cysteine is a puzzling phenomenon. Enzymes inhibited by a 
common metabolite constantly present in high amounts would be extremely inefficient. In SclA, 
the Ki
app for L-cysteine was determined to be 0.55 ± 0.09 mM while the Km
app for L-selenocysteine 
was 3.55 ± 0.32 mM. In hSCL, the Ki
app is 5.85 mM while the Km
app for L-selenocysteine is 0.50 
mM [39]. In contrast to hSCL, SclA seems to have a greater affinity for L-cysteine than L-
selenocysteine (~6.5-fold difference between Km
app and Ki
app), even though it turns over L-
selenocysteine better than L-cysteine. The difference in binding affinities may suggest an overall 
distinction between the two enzymes—indeed, comparing prokaryotic and eukaryotic enzymes is 
difficult and may allow for misinterpretation of data without the aid of a crystal structure (in the 
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case of SclA). In terms of kinetic changes, H100K exhibited the weakest affinity for L-cysteine as 
an inhibitor (~2.3-fold increase in Ki
app). The lysyl residue may have changed the pH of the active 
site in a way that slightly disfavors binding of L-cysteine. Contrastingly, H100A had the highest 
binding affinity to L-cysteine, but it is unclear whether or not its Ki
app is significant enough to make 
that claim (~1.4-fold decrease). It is important to note that the inhibition studies in this work were 
carried out using only four concentrations of substrate, and this may have produced results that are 
probably not indicative of the “true” inhibitor constants for each enzyme. For a full investigation 
into the L-cysteine inhibition, more data points would be sufficient. Overall, H100 mutagenesis 
did not seem to affect binding of L-cysteine as much as it did L-selenocysteine catalysis which 
may reveal something about the pKa of C341’s sulfhydryl group. 
H100 does not solely confer specificity for L-selenocysteine 
Because D146K in hSCL resulted in loss of specificity, we believed a similar charge 
inversion in H100D would generate a similar result. Unexpectedly, the HS- activity of H100D did 
not seem to differ significantly from the rest of the mutants, implying that the pKa of C341 may 
not have been lowered enough to display non-specificity—this could be due to another unknown 
residue nearby. Furthermore, the mutants were only able to generate HS- when there was a 
substantial amount of enzyme in the assay—the flaw with this method lies in the fact that the 
protein samples are not completely pure. It is not possible to obtain 100% pure protein from a 
preparation; moreover, the sensitivity of Coomassie stains is not high enough to detect all the 
contaminants in a protein prep unless the gel is overloaded. While Figure 4D shows pure enzymes 
at 2.5 μg, another gel was run with 5.0 μg of enzymes to check for contaminants (data not shown). 
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Faint contaminating bands appeared in all lanes, and this may be problematic if the methylene blue 
assay is overloaded with 100 μg/mL of enzyme. Therefore, it is probable that the CDS activity in 
Figure 15B may be due to contributions of “hidden” CDS activities from contaminants from each 
prep. Nevertheless, the mere appearance of CDS activity may still be significant. Depending on 
how the data is analyzed, there are two interpretations: 1) the appearance of weak CDS activity is 
novel and suggests that SCLs are not as specific as previously thought, or 2) the CDS activity 
generated in this study may be due to an artifact or contaminant from protein purification. Since 
the pKa of C341 may be important in determining specificity, it is recommended that future 
experiments must be tuned towards “tweaking” the pKa of C341 via pH-activity studies of the 
enzyme and mutagenesis of other neighboring residues. 
Thiol-based reductants affect the kinetics of NifS-like proteins 
Historically, thiol-based reductants like DTT have been used to assay the SCL and CDS 
activities of NifS-like enzymes, but this creates an inherent problem when determining the pKa of 
the catalytic sulfhydryl: the reductant itself may be reacting with the sulfhydryl, thereby affecting 
the kinetics of the enzyme. Because it has been observed that DTT nucleophilically attacks and 
displaces the sulfur atom bound to the catalytic thiolate in IscS, it can be assumed that a similar 
reaction probably occurs in SclA [33]. In fact, it has been shown in Slr0387, a CDS in 
Synechocystis sp. PCC 6803, that the mechanism of persulfide cleavage by DTT is due to the 
dithiol forming a complex with PLP in order to position itself for attacking the catalytic sulfhydryl; 
moreover, the authors observed that this is the rate-determining step of catalysis, thus confounding 
any kinetic studies when DTT is the reductant [67]. Furthermore, the authors made the observation 
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that some CDSs including Slr0387 are subject to inhibition by L-cysteine when DTT is the 
reductant [67]. They hypothesize that this may be due to both thiol-based molecules competing for 
the same catalytic sulfhydryl where, in one scenario, a DTT-PLP complex prevents L-cysteine 
from binding, and conversely, L-cysteine prevents DTT from binding to cofactor [67]. Lastly, the 
authors found that using tris(2-carboxyethyl)phosphine (TCEP), a nonthiol, as a reductant was 
much more efficient in cleaving the persulfide bond compared to DTT (~10-fold increase in kcat) 
and did not seem to exhibit a rate-limiting effect [67]. If any future studies on the mechanism of 
SclA are to be undertaken, the utilization of a non-thiol reductant (like TCEP) may eliminate any 
confounding variables when attempting to determine the pKa of C341. 
The inefficiency of SclA may prevent HSe- toxicity in vivo 
It is important to note that all Km
app values were in millimolar amounts, well above the 
physiological concentration of L-selenocysteine which is expected to be in low micromolar levels 
in the cell. Because HSe- is incredibly toxic, uncontrolled release of this reactive species would 
not be favorable for any organism. Therefore, it may make sense that the relatively slow 
physiological turnover of this enzyme due to incredibly low substrate affinity serves as an internal 
control mechanism to prevent accidental poisoning of the cell. Moreover, the higher affinity for 
L-cysteine as evidenced by the Ki
app values implies that the enzyme would almost always bind the 
inhibitor rather than its preferred substrate considering the fact that there is most likely ~1000-fold 
more L-cysteine than L-selenocysteine in the cytosol. While this undoubtedly decreases the 
enzyme’s efficiency for L-selenocysteine degradation even more, one must further consider the 
repercussions of releasing free HSe- into the cytosol such as thiol-mediated redox cycling [28, 29]. 
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Coupled with its weak L-selenocysteine binding affinity, it is possible that the enzyme contains a 
sophisticated feedback mechanism to control HSe- production as soon as it disengages the 
ribosome by sequestering itself with the large amount of cellular L-cysteine. If the enzyme were 
immediately “shut off” by the physiological concentration of L-cysteine to prevent HSe- release, 
it may stand to reason that an additional factor may be required for the enzyme to “turn on” again 
and carry out its true biological function, whatever it may be. 
SclA may channel HSe- to an unknown electron acceptor 
While a role for SCLs has not been elucidated, it has been shown that some NifS-like 
enzymes can participate in mobilizing HSe- from L-selenocysteine to SPS in vitro [68-70]. The 
results of these mobilization studies heavily imply that the chemical species in vivo is most likely 
a selenium intermediate bound to the catalytic cysteine of SCLs that is meant to be transferred to 
another protein; in other words, SCLs probably do not randomly release HSe- into the cellular 
environment. Because E. faecalis contains one known enzyme that requires selenium, it is 
hypothesized that SclA may contribute overall to the synthesis of that enzyme. Moreover, because 
this enzyme is a selenium-dependent XDH, E. faecalis therefore possesses this uncharacterized 
third trait of specific incorporation—thus, the generation of HSe- from L-selenocysteine for SPS 
via SclA may be the first step in this pathway. Indeed, the specificity of this enzyme towards L-
selenocysteine would be crucial in synthesizing XDH. Since E. coli SPS does not recognize HS- 
and produce SPO3, it may be true that the selD gene product in E. faecalis may also not recognize 
the trace amounts of HS- weakly generated by SclA [30]. This assumption would most likely 
explain a mechanism to prevent accidental incorporation of a sulfur cofactor in place of selenium, 
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and while this has not been observed in vivo, most molybdenum hydroxylases tend to contain labile 
sulfur atoms in their active sites [71].  
In the same genetic locus as SclA, SelD, and XDH, other genes have been identified as 
putatively involved in SDMH biosynthesis such as yqeB and yqeC; past studies have shown that 
yqeB and yqeC generally co-localize with selD in many organisms lacking the ability to synthesize 
selenoproteins and selenium-containing tRNAs [42, 46]. These two genes may encode products 
that function to shuttle selenium in the SDMH biosynthetic pathway. The rationale for this 
“selenium-channeling” hypothesis stems from the fact that most CDSs are known to mobilize 
sulfur via protein-protein interactions; for example, in A. vinelandii, the Fe-S clusters in 
nitrogenase are synthesized by an interaction where NifS presents its thiol-bound sulfur 
intermediate to NifU, a scaffolding protein [72]. In another example from both A. vinelandii and 
E. coli, IscS carries out a similar reaction with its partner, IscU [73, 74]. The similarities between 
the two subclasses of NifS-like proteins cannot be overstated—if CDSs can mobilize sulfur, surely 
SCLs can mobilize selenium. Because SCLs have low affinity for L-selenocysteine according to 
their millimolar Km
app constants, it is possible that they may require the presence of other proteins 
to vastly increase effective substrate affinity, assuming that they do mobilize selenium. Indeed, 
releasing HSe- would be disastrous for the cell, and with the molecule itself being oxygen-labile, 
exposure to the cytosol would probably oxidize it to an unusable form. As of yet, SCLs are not 
known to have any in vivo electron acceptors, but the gene products of selD, yqeB, and yqeC may 
be likely candidates in the case of SclA. An analysis of SclA’s kinetics in the presence of all three 
proteins is recommended to probe this question. 
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A crystal structure of SclA may be required for future studies 
Since the hypothesis of H100 determining specificity was based on a sequence alignment, 
future studies may benefit from generating a crystal structure of SclA instead. As stated before, it 
is difficult to carry out mechanistic studies without a crystal structure as a guide, and while the 
alignments and models offered good estimates of the SclA active site, it still does not show us the 
full biochemical picture. Because the models in Figure 2C-2G were generated using B. subtilis 
SufS as a homology template, the 3-D spatial arrangement may be entirely skewed. An important 
characteristic of hSCL’s specificity is partly due to a mechanical conformational change that is 
dependent on substrate-binding. As determined by the hSCL crystal structure, C388 is located on 
a dynamic segment that shifts whenever substrate is bound in the active site [50]. The dynamic 
segment has been found in both an “open” conformation (with C388 exposed to solvent) and a 
“closed” conformation (with C388 sequestered in the active site near the cofactor) [50]. Visualized 
in Figure 2A, this closed conformation may prevent accidental release of HSe- into the cytosol 
while simultaneously preventing it from becoming oxidized. In SclA, however, it is unknown if a 
similar mechanism exists, and this is impossible to visualize with just a putative model because 
SufS does not contain this mechanism. Using a non-SCL as a template to model SclA may present 
a flawed view of the active site; therefore, a crystal structure may be the best solution to this 











Table 1: Oligonucleotides used for site-directed mutagenesis 
Primer name 
 
Nucleotide sequence (5’ → 3’) 
H100K FWD AAAGCAGTAGCTAGACCTCTTCACTTAC 
H100D FWD GATGCAGTAGCTAGACCTCTTCACTTAC 
H100A FWD GCTGCAGTAGCTAGACCTCTTCAC 
H100N FWD AATGCAGTAGCTAGACCTCTTCACTTAC 
H100 REV ATGTTCTAACATAGTCGTAATCACATGGTCG 


















WT 3.55 ± 0.32 6.38 ± 0.25 4.43 ± 0.17 1.25 0.55 ± 0.09 
H100K 3.71 ± 0.17 8.34 ± 0.13 5.79 ± 0.09 1.56 1.24 ± 0.15 
H100D 5.02 ± 0.49 6.50 ± 0.30 4.52 ± 0.21 0.90 0.62 ± 0.07 
H100A 1.86 ± 0.13 6.53 ± 0.14 4.54 ± 0.10 2.44 0.39 ± 0.05 
H100N 3.38 ± 0.26 9.89 ± 0.25 6.86 ± 0.17 2.03 0.57 ± 0.06 
Standard deviations were calculated by GraphPad Prism 8 and are presented as “± SD”. Ki
app 
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